Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Survival of myelodysplastic syndrome patients after azacitidine therapy
Complex karyotype associated with poor ORR in MDS patients.
»
04/20/26
Monitoring and treatment patterns of von Hippel-Lindau disease-associated central nervous system hemangioblastomas
VHL-CNS-Hb patients had higher rates of pain management drug use.
»
04/20/26
Improved outcomes of the refined risk-stratification and risk-adapted therapy in children with acute myeloid leukemia: final results of the AIEOP AML 2013
Levels of MRD after 1st and 2nd induction course strongly influenced EFS probability.
»
04/20/26
Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas
Experimental targeting of newly identified immune mechanisms improved therapeutic responses in vivo.
»
04/20/26
Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups
Multiplex assay enables direct detection of early-stage PDAC from whole plasma.
»
04/21/26
Impact of the Nadir Androgen Receptor Signaling Inhibitor-Derived Integrative Response Model in Real-World Patients With Metastatic Castration-Sensitive Prostate Cancer.
NADIR model demonstrated acceptable discrimination for predicting early favorable PSA response.
»
03/23/26
Comparing dermatologists' and artificial intelligence heat maps in dermoscopic image analysis via eye tracking.
Dermatologists and DEXI heat maps showed substantial overlap.
»
11/10/25
Identifying ovarian cancer with AI analysis of abdominal CT scans.
DL using segmented abdominal-pelvic CT scans demonstrate strong potential for distinguishing EOC.
»
01/21/26
Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies.
Most common treatment-related treatment-emergent adverse events among patients: fatigue (15%), rash (12%), pruritus (10%), infusion-related reaction (10%).
»
02/18/26
Efficacy of first-line immunochemotherapy across KRAS mutation subtypes in advanced lung adenocarcinoma.
First-line immunochemotherapy yields comparable efficacy across KRAS subtypes.
»
01/13/26
< Prev
Next >